Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-03-11 @ 4:36 PM
Study NCT ID:
NCT01977651
Status:
COMPLETED
Last Update Posted:
2024-12-06
First Post:
2013-10-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
Sponsor:
Astellas Pharma Global Development, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-25
Start Date Type:
ACTUAL
Primary Completion Date:
2016-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-11
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-31
First Submit QC Date:
None
Study First Post Date:
2013-11-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-11-13
Results First Submit QC Date:
None
Results First Post Date:
2020-12-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-19
Last Update Post Date:
2024-12-06
Last Update Post Date Type:
ACTUAL